Developmental neurotoxicity testing: Scientific approaches towards the next generation to protect the developing nervous system of children. An overview of the Developmental Neurotoxicity Symposium in 2011

Congenital Anomalies

Volumn 52, Issue 3, 2012, Pages 119-121

  Aoyama, Hiroaki ^a  

^a INSTITUTE OF ENVIRONMENTAL TOXICOLOGY   (Japan)

Author keywords

Behavioral Teratology Meeting; Developmental Neurotoxicology Committee; OPPTS 870.6300; Test guideline; TG 426

Indexed keywords

ARTICLE; CHILD; DEVELOPMENTAL NEUROTOXICITY; HUMAN; MEDICAL LITERATURE; MEDICAL SOCIETY; METHODOLOGY; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RATING SCALE;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CHILD; GUIDELINES AS TOPIC; HAZARDOUS SUBSTANCES; HUMANS; NEUROTOXICITY SYNDROMES; RESEARCH DESIGN; TOXICITY TESTS;

EID: 84865550521     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/j.1741-4520.2012.00366.x     Document Type: Article

References (30)

1. Coecke S, Goldberg AM, Allen S etal. 2007. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect 115:924-931.
2. Crofton KM, Foss JA, Hass U, Jensen KF, Levin ED, Parker SP. 2008. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol 30:266-287.
3. Crofton KM, Makris SL, Sette WF, Mendez E, Raffaele KC. 2004. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotoxicol Teratol 26:345-352.
4. Crofton KM, Mundy WR, Lein PJ etal. 2011. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX 28:9-15.
5. Ema M, Fukui Y, Aoyama H etal. 2007. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD guideline for the testing of chemicals, proposal for a new guideline 426, developmental neurotoxicity study, draft document (October 2006 version), and on the draft document of the retrospective performance assessment of the draft test guideline 426 on developmental neurotoxicity. Congenit Anom Kyoto 47:74-76.
6. Fukui Y, Ema M, Fujiwara M etal. 2004. Comments from the Behavioral Teratology Committee of the Japanese Teratology Society on OECD guideline for the testing of chemicals, proposal for a new guideline 426, developmental neurotoxicity study, draft document (September 2003). Congenit Anom Kyoto 44:172-177.
7. Fukunishi K, Terada Y, Tachibana T, Tanimura T. 1998. Collaborative behavioral teratology study of phenytoin: a test battery for neurobehavioral developmental toxicity in rats. Congenit Anom Kyoto 38:117-141.
8. Grandjean P, Landrigan PJ. 2006. Developmental neurotoxicity of industrial chemicals. Lancet 368:2167-2178.
9. Julvez J, Grandjean P. 2009. Neurodevelopmental toxicity risks due to occupational exposure to industrial chemicals during pregnancy. Ind Health 47:459-468.
10. Kuwagata M, Muneoka KT, Ogawa T, Takigawa M, Nagao T. 2004. Locomotor hyperactivity following prenatal exposure to 5-bromo-2′-deoxyuridine: neurochemical and behavioral evidence of dopaminergic and serotonergic alterations. Toxicol Lett 152:63-71.
11. Kuwagata M, Nagao T. 1998. Behavior and reproductive function of rat male offspring treated prenatally with 5-bromo-2′-deoxyuridine. Reprod Toxicol 12:541-549.
12. Kuwagata M, Ogawa T, Muneoka K, Shioda S. 2011. Hyperactivity induced by prenatal BrdU exposure across several experimental conditions. Congenit Anom Kyoto 51:177-182.
13. Kuwagata M, Ogawa T, Nagata T, Shioda S. 2007. The evaluation of early embryonic neurogenesis after exposure to the genotoxic agent 5-bromo-2′-deoxyuridine in mice. Neurotoxicology 28:780-789.
14. Kuwagata M, Ogawa T, Shioda S, Nagata T. 2009. Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study. Int J Dev Neurosci 27:399-405.
15. Makris SL, Raffaele K, Allen S etal. 2009. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect 117:17-25.
16. Mendola P, Selevan SG, Gutter S, Rice D. 2002. Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment Retard Dev Disabil Res Rev 8:188-197.
17. Nagao T, Kuwagata M, Saito Y. 1998. Effects of prenatal exposure to 5-bromo-2′-deoxyuridine on the developing brain and reproductive function in male mouse offspring. Reprod Toxicol 12:477-487.
18. Nishimura T, Iwase T, Hashimoto Y, Tanimura T. 2001. Evaluation of a core battery of tests for detecting behavioral dysfunction of rat offspring induced by retinoic acid: collaborative work II of the Japanese behavioral teratology committee. Congenit Anom Kyoto 41:156-168.
19. OECD (Organisation for Economic Co-operation and Development). 2007. OECD guidelines for the testing of chemicals, section 4: health effects. Test No. 426: Developmental neurotoxicity study. http://www.oecd.org/dataoecd/20/52/37622194.pdf
20. Ogawa T, Kuwagata M, Hori Y, Shioda S. 2007. Valproate-induced developmental neurotoxicity is affected by maternal conditions including shipping stress and environmental change during early pregnancy. Toxicol Lett 174:18-24.
21. Ogawa T, Kuwagata M, Muneoka KT, Shioda S. 2005. Neuropathological examination of fetal rat brain in the 5-bromo-2′-deoxyuridine-induced neurodevelopmental disorder model. Congenit Anom Kyoto 45:14-20.
22. Rees DC, Francis EZ, Kimmel CA. 1990. Qualitative and quantitative comparability of human and animal developmental neurotoxicants: a workshop summary. Neurotoxicology 11:257-269.
23. Tachibana T. 1989. Behavioral teratogenic effect of methylmercury and d-amphetamine: meta-analysis and power analysis of data from the collaborative behavioral teratology study of national center for toxicological research. Teratology 40:93-100.
24. Tachibana T. 1990. Effect of sample size on reproducibility of behavioral teratological study results: a computer simulation experiment using data from the collaborative behavioral teratology study of the national center for toxicological research. Teratology 42:207-214.
25. Tachibana T, Narita H, Ogawa T, Tanimura T. 1998. Using postnatal age to determine test dates leads to misinterpretations when treatments alter gestation length: results from a collaborative behavioral teratology study in Japan. Neurotoxicol Teratol 20:449-457.
26. Tachibana T, Terada Y, Fukunishi K, Tanimura T. 1996. Estimated magnitude of behavioral effects of phenytoin in rats and its reproducibility: a collaborative behavioral teratology study in Japan. Physiol Behav 60:941-952.
27. Tanimura T. 1986. Collaborative studies on behavioral teratology in Japan. Neurotoxicology 7:35-45.
28. Tanimura T. 1992. Update on the activities of the Japanese behavioral teratology meeting. Congenit Anom Kyoto 32:S7-S20.
29. Tanimura T, Kihara T. 1987. Behavioral teratology symposium 'advances in behavioral teratology testings'. Congenit Anom Kyoto 27:95-101.
30. US EPA (United States Environmental Protection Agency). 1998. Health effects guidelines OPPTS 870.6300: developmental neurotoxicity study. http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2009-0156-0042